Clinical Trial Update: Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating combination chemotherapy with or without veliparib in stage IV head and neck cancer; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Head and Neck Squamous Cell Carcinoma, Stage IVA Oropharyngeal Carcinoma AJCC v7 | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-05